?? 5 Days Left! ?? We are thrilled to announce that?Keara Sauber, CEO of?Sauber Capital,?will join us to discuss?Building an Investment Case: Translational and Commercialization Experience. With more than two decades of experience, Keara is a seasoned executive with a strong biotech, venture capital, and finance background. She began her career at GlaxoSmithKline (GSK) before transitioning into leadership roles in the biopharmaceutical industry, including serving as CEO of a biosimilar company. As a co-founder and investor, Keara has built and scaled multiple ventures, leveraging her capital stacks, fundraising, and strategic growth expertise. She is actively involved in venture capital through her work with Gaingels, focusing on early-stage investments, company creation, and portfolio growth. ???Learn more about our Speakers & Register Today with our Special Discount Code "LASTCALL" https://lnkd.in/earzekFG #womenshealth #powerofx #womenshealthinvestment
关于我们
Cure is a vibrant healthcare innovation campus in the heart of New York City with a mission to advance health. Supporting healthcare and life science entrepreneurs, Cure offers digital and in-person content, programming, and learnings on critical health and business topics. The campus at 345 Park Avenue South features laboratory and business facilities, office space and premium event venues, including an education center, conference center, and iconic rooftop terrace. Residents and members collaborate across the spectrum of healthcare and focus on diagnostic, device, drug development and production as well as care delivery and public health. For more information, please visit wewillcure.com.
- 网站
-
www.wewillcure.com
Cure.的外部链接
- 所属行业
- 健康与公共事业
- 规模
- 11-50 人
- 总部
- New York,NY
- 类型
- 私人持股
- 创立
- 2020
- 领域
- Life Science、Incubator、Fellowships、healthcare、scientists、doctors、researchers、digitalhealth、science、health、startup、doctors 、ecosystems、business、AI、education、cancer、entreprenuer、health equity、access to care、global health、artificial intelligence、events和start-ups
地点
-
主要
345 Park Ave S
US,NY,New York,10010
Cure.员工
-
David Ewing Duncan
Journalist, Author, Researcher, Curator, and Advisor
-
Lauren Ruotolo
Creative Media Partnerships & Executive Producer | Keynote Speaker | Disability Advocate
-
Paul Oestreicher
Strategic Communications; Public and Media Relations; Risk/Issues/Crisis/Reputation Management. Thought Leader; Mentor, and Trusted…
-
Charles Kim
COO & CFO | Healthcare, Sustainability, Food & Beverage
动态
-
A novel IV treatment yields first-of-its-kind genetic correction in living patients, signaling a new era in precision medicine. Read more about what scientists call a medical first, from Cambridge-based Beam Therapeutics who has successfully corrected a disease-causing genetic mutation in living patients, demonstrating a new approach for people with a rare but devastating condition that destroys both lungs and liver. https://lnkd.in/dBrX5sFF
-
?? One Week Left! ?? We’re counting down to the Power of X Summit: Solutions for an Untapped Market, happening March 24-25, 2025! And we’re excited to announce that Viq Pervaaz, SVP, Life Sciences & Healthcare at the New York City Economic Development Corporation, will join us on stage! Viq will share how #NYC is leveraging its world-class resources to address the unmet medical needs of women—and how the city is scaling programs, maximizing data, and improving healthcare delivery to drive better outcomes for local communities. #womenshealth #healthequity Check out the Full Agenda & Register Today: https://lnkd.in/exgvH-Wv
-
-
This past week, at investment banking firm Jefferies recent biotech conference in Miami, a policy panel featuring John F. Crowley CEO of the Biotechnology Innovation Organization, Joel White of Horizon Government Affairs, and Raghav Aggarwal from BGR Group said the political shift under President Trump could ultimately benefit the biotech sector. Read more about why industry leaders and analysts predict policy shifts could benefit innovation & drug pricing reform. https://lnkd.in/e3Xj3pmf
-
What if women's ovaries could stay healthier, longer? Read more on how NY-based Celmatix Therapeutics is developing a first-in-class therapy to extend ovarian function—potentially reducing risks of heart disease, osteoporosis, & cognitive decline. A game-changer for women's health & aging! #womenshealth #therapeutics Piraye Beim
-
??? Power of X Summit: Solutions for an Untapped Market -- Panel Announcement ?? Advocating for Lasting Impact ?? How do we keep women’s health at the top of the agenda? Join our panel of experts to explore how companies, advocates, and policymakers can drive lasting change through research, funding & collaboration. Panelists will share expert strategies & solutions to build upon the women's health movement: ?? Greg Simon ?? E. Cartier Esham, Ph.D. ?? Jennifer Luray ?? Seileen Mullen ?? Liz Powell ?? Register Today: https://lnkd.in/earzekFG #womenshealth #publichealth #publicpolicy #womensresearch #powerofX
-
-
?? SPEAKER ANNOUNCEMENT With autoimmune diseases affecting approximately 8% of the U.S. population, 78% of whom are women. Rekha Kumar, M.D, M.S., Associate Professor of Clinical Medicine at Weill Cornell Medicine, will help us navigate and identify why women are more prone to #autoimmunediseases like #Rheumatoidarthritis, #Lupus, #Psoriasis, and #Psoriaticarthritis. Dr. Rekha Kumar is recognized as an international leader in the field of Obesity Medicine. She is a practicing endocrinologist in New York City and served as the former medical director of the American Board of Obesity Medicine. Dr. Kumar's expertise includes the clinical assessment of patients' obesity and metabolic syndrome, the effect of obesity on reproductive health and fertility, and thyroid disease. Alongside her clinical practice, Dr. Kumar serves as the Head of Medical Affairs for a healthcare technology company called Found, which focuses on expanding access to obesity care. ???Learn more about our speakers & register today: https://lnkd.in/earzekFG #autoimmune #womenshealth #powerofx #womenshealthinvestment
-
-
There is no standard path from bench to bedside, says Tingting Zhang-Kharas, PhD Head of Johnson & Johnson’s JLABS program in the Northeast and mid-Atlantic states. No two innovations are alike, competitive landscapes differ and skeptical investors often dictate scientific milestones – including specific experiments – that must be achieved before they’re willing to back the product’s development, she said. Read more from Cure writer Steve Sternberg on how Academic institutions and industry leaders are forging new pathways to commercialize cutting-edge research. https://lnkd.in/eX5tXdu9 #AUTM2025
-
??? Keynote Speaker Announcement! We are thrilled that?Carolee Lee, CEO & Founder?of Women's Health Access Matters Matters,?will be our opening keynote speaker at Power of X Summit: Solutions for an Untapped Market. “Investing in the health of women is one of today’s most compelling business opportunities—a high-growth market with untapped potential..” — Carolee Lee, CEO & Founder of WHAM Carolee will present highlights from the latest WHAM Report: The Business Case for Accelerating Women’s Health Investment which presents undeniable data spotlighting the immense opportunities waiting to be unlocked in the women’s health space. ???Learn more about our speakers & register today: https://lnkd.in/earzekFG #womenshealth #powerofx #womenshealthinvestment
-
-
Experts from the venture capital and health technology sectors share insights into where investment dollars flow and how emerging trends could redefine patient care. Read more about the latest trends: https://lnkd.in/euXMkwqB #venturecapital #healthcaretech